Varagon Capital Partners has provided a credit facility to back Morgan Stanley Capital Partners’ acquisition of US HealthConnect, a provider of digital education strategies and engagement data solutions for pharmaceutical, biotech, diagnostic and device companies. No financial terms were disclosed. Varagon served as administrative agent, joint lead arranger and bookrunner on the financing.
New York, NY, November 5, 2020 – Varagon Capital Partners (Varagon) today announced it is serving as Administrative Agent, Joint Lead Arranger and Bookrunner on a senior secured credit facility to support the acquisition of US HealthConnect (USHC) by investment funds managed by Morgan Stanley Capital Partners (MSCP).
Founded in 1999, US HealthConnect (USHC) is the worldwide leader in digital education strategies and engagement data solutions for pharmaceutical, biotech, diagnostic, and device companies. Its award-winning platforms drive value to healthcare professionals through education strategies designed to improve the practice of medicine and to clients through data-driven analytics on platform engagements. USHC companies include ReachMD, Global Learning Collaborative, Prova Education, Omnia Education, Medtelligence, Kynectiv, Winding River Productions, Connect Healthcare Communications, and AGILE.
About Varagon Capital Partners
Varagon Capital Partners is an asset manager focused on direct lending to middle market companies. Varagon invests across the capital structure and offers flexible financing solutions to meet the needs of borrowers and private equity sponsors. Varagon manages funds and accounts on behalf of institutional investors that seek exposure to high-quality, directly-originated middle market loans. Since its founding in 2014, Varagon has made over $15.5 billion of financing commitments to over 185 companies.
For more information about Varagon, visit www.varagon.com.